Solid biosciences outlines key priorities for advancing diversified neuromuscular and cardiac development pipeline and establishing leadership in precision genetic medicines

- duchenne : dosed four patients in inspire duchenne clinical trial; sgt-003 has been well tolerated in all patients with no saes observed; initial three patient data expected q1 2025 -
SLDB Ratings Summary
SLDB Quant Ranking